A variety of factors, including the number of de~brillation electrodes and shocking capacitance, may in_uence the de~brillation ef~cacy of an implantable de~brillator system. Therefore, the purpose of this study was to compare the de~brillation energy requirement using a 125 uF two-electrode de~brillation system and a 90 uF three-electrode de~brillation system. Methods and Results: The de~brillation energy requirements measured with both systems were compared in 26 consecutive patients. The two-electrode system used a single transvenous lead with two de~brillation coils in conjunction with a biphasic waveform from a 125 uF capacitor. The three-electrode system used the same transvenous lead, utilized a pectoral implantable de~brillator generator shell as a third electrode, and delivered the identical biphasic waveform from a 90 uF capacitor. The two-electrode system was associated with a higher de~brillation energy requirement (10.8Ϯ5.5 J) than was the three-electrode system (8.9Ϯ6.7 J, p Ͻ 0.05), however, the leading edge voltage was not signi~cantly different between systems (361Ϯ103 V vs. 397Ϯ123 V, P ϭ 0.07). The two-electrode system also had a higher shocking resistance (49.0Ϯ9.0 ohms vs. 41.4Ϯ7.3 ohms, p Ͻ 0.001) and a lower peak current (7.7Ϯ2.6 A vs. 10.1Ϯ3.7 A, p Ͻ 0.001) than the three-electrode system.
A variety of factors can in_uence the de~brillation ef~cacy of a non-thoracotomy de~brillation system. These factors include waveform, electrode con~gura-tion, capacitance and the number of de~brillation electrodes [1] [2] [3] [4] . Incorporation of these variables into the design of a de~brillation system may improve de~bril-lation ef~cacy. Therefore, the purpose of this study was to compare, using a prospective randomized study design, the de~brillation energy requirement associated with a dual coil transvenous de~brillation system with a de~brillation system that utilizes smaller capacitance and three electrodes, including a pectoral generator de~brillator shell that functions as a shocking electrode.
Methods

Study design
Based on previous experience, the two-electrode de~-brillation system was expected to have a de~brillation energy requirement of 12Ϯ5 J. To detect a 25% change in de~brillation energy requirement, i.e., 3 J, with 80% power, a prospective power calculation demonstrated that 24 patients were required. A prospective decision was made to enroll 30 patients in the event some patients were not able to complete the entire protocol.
Patient population
The mean age of the 30 patients included in this study was 65Ϯ12 years, the mean left ventricular ejection fraction was 0.32Ϯ0.17, and 28 of the patients were male. Coronary artery disease was present in 27 pa-tients, two patients had dilated nonischemic cardiomyopathy, and one patient had cardiac sarcoidosis. The presenting symptom or arrhythmia was aborted sudden death in thirteen patients, syncope in 12 patients, and monomorphic ventricular tachycardia in~ve patients. All patients underwent baseline electrophysiologic testing, and electropharmacologic testing with a mean of 0.5Ϯ0.6 antiarrhythmic drugs was unsuccessful before device implantation.
Of the 30 patients enrolled in this study, four did not complete the investigational protocol. The protocol was not completed in one patient who developed incessant ventricular tachycardia during de~brillator implantation, in two patients in whom the implantation procedure was prolonged due to technical dif~culties which precluded additional de~brillation energy requirement testing, and in one patient who was inadvertently tested with an incorrect waveform. These four patients were similar to the remaining 26 patients who completed the de~brillation energy requirement testing in age, gender, ejection fraction, type of heart disease, or clinical presentation.
Implantation technique of de~brillation systems
All patients came to the operating room in a post-absorptive state. All antiarrhythmic drug therapy was stopped at least~ve half lives prior to device implantation, with the exception of 11 patients in whom amiodarone therapy had been ineffective. General anesthesia was induced with fentanyl or its derivatives and the patients were paralyzed with vecuronium bromide. Maintenance anesthesia was achieved with inhalational agents: nitrous oxide, halothane, iso_urane, or ethrane, in combination with intravenous fentanyl.
A transvenous lead with two coils (Endotak models 0074, 0075, and 0115, Cardiac Pacemakers Inc., St. Paul, MN) was implanted in each patient via the left subclavian vein. The lead is tined with a distal coil of 379 mm 2 and a proximal coil of 617 mm 2 . The distal coil is 1.2 cm proximal from the end of the lead and is separated by a distance of 11.5 cm from the proximal coil. The distal coil was positioned in the right ventricular apex with the aid of _uoroscopy, which resulted in the proximal coil being positioned in the right atrium or at the right atrium superior vena cava border. A 50 cm 3 titanium generator shell was positioned subcutaneously in an infraclavicular prepectoral pocket.
De~brillation energy requirement testing
Thirty patients undergoing de~brillator implantation were enrolled in this study after written informed consent was obtained under a protocol approved by the Committee for Human Research at the University of Michigan. The two-electrode system used a biphasic de~brillation pulse from a 125 uF capacitor, delivered between the proximal and distal coils of the transvenous lead. The biphasic waveform had a~rst phase tilt of 60% and a second phase tilt of 50%, and the leading-edge voltage of the second phase was equal to the trailing-edge voltage of the~rst phase. The threeelectrode system used an identical biphasic waveform which was delivered from a 90 uF capacitor. In this de~brillation system, the distal coil served as one electrode, and the proximal coil and the 50 cm 3 titanium shell functioned together as the second electrode.
The de~brillation energy requirement was determined for the two-electrode system and for the threeelectrode system in random order. Ventricular~brilla-tion was induced using one to three seconds of alternating current. Using an external de~brillator, the appropriate shock was delivered 10 seconds after the initiation of ventricular~brillation. A step-down protocol was utilized to determine the de~brillation energy requirement. The delivered energy was given in the following order until the shock failed to convert ventricular~brillation to sinus rhythm: 20, 15, 10, 8, 5, and 3 J. The de~brillation energy requirement was de~ned as the lowest energy that converted ventricular~bril-lation to the normal rhythm. When de~brillation was successful at 3 J, the de~brillation energy requirement was de~ned as 3 J. At least~ve minutes were allowed to elapse between each induction of ventricular~brilla-tion. The amount of delivered energy, peak voltage, peak current, system impedance and waveform duration for each de~brillation was measured and recorded from the external de~brillator. Only the 26 patients that completed de~brillation energy requirement testing with both de~brillation systems were included in the analysis.
Statistical analysis
Continuous variables are expressed as the mean Ϯ 1 SD. Paired and unpaired tests were used as appropriate. A chi square analysis was used to compare nominal variables. A relationship between continuous variables was assessed using linear regression analysis. Probability values less than 0.05 was considered statistically signi~cant.
Results
The de~brillation energy requirement was 10.8Ϯ5.5 J for the two-electrode system and was 8.9Ϯ6.7 J for the three-electrode system (p Ͻ0.05; Figure 1) . However, the leading edge voltages were not signi~cantly different (361Ϯ103 V vs. 397Ϯ123 V, p ϭ 0.07). The de~bril-lation resistance (49.0Ϯ9.0 ohms) and the pulse duration (14.1Ϯ1.8 ms) were greater for the two-electrode system as opposed to the three-electrode system (41.4Ϯ7.3 ohms, p Ͻ 0.001; 7.8Ϯ1.1 ms, p Ͻ 0.001, respectively). The current for the two-electrode system was lower than the current for the three-electrode system (7.7Ϯ2.6 A, vs. 10.1Ϯ3.7 A, p Ͻ 0.001). A de~bril-lation energy requirement less than or equal to 5 J was achieved in 4 patients with the two-electrode system and in 13 patients with the three-electrode system (p Ͻ 0.001).
There was no signi~cant relationship between the de~brillation energy requirement, leading edge voltage, current, or resistance and with patients characteristics including age, gender, type of heart disease, mode of presentation, or recent use of amiodarone.
Discussion
Major~ndings
This study demonstrates that a de~brillation system which utilizes a short-duration biphasic waveform from a 90 uF capacitor and which incorporates the implantable de~brillator generator as a third electrode decreases the de~brillation energy requirement by approximately 20% compared to a two-electrode transvenous lead system used in conjunction with a 125 uF capacitor. Additionally, the likelihood of achieving a de~brillation energy requirement of 5 J or less is signi~cantly greater with the three-electrode de~bril-lation system. This decrease in de~brillation energy requirement is associated with a decrease in de~brilla-tion resistance and waveform duration, while the current increases and the leading edge voltage does not change signi~cantly.
Low de~brillation energy requirements
The 20% reduction in the de~brillation energy requirement with the 3-electrode de~brillation system translates into approximately a 2 J improvement in the debrillation energy requirement. This may appear to be a small and insigni~cant improvement relative to previous improvements. Early attempts at implantation of non-thoracotomy de~brillation systems failed in up to 30% of patients because of high de~brillation energy requirements [5] [6] [7] . The use of biphasic waveforms lowered de~brillation energy requirement, which improved implantation success, and also eliminated the routine need for additional electrodes [8] [9] [10] . Now that a de~brillation energy requirement of 10 to 12 J is frequently obtained, further reductions of the de~bril-lation energy requirement obtained with modi~cations of the de~brillation system will likely be in the range of 10 to 25%. This represents a 1 to 2.5 J reduction of the de~brillation energy requirement, similar to that seen in the present study. Therefore, achieving a 20% reduction in de~brillation energy requirement is clinically relevant, and obtaining a de~brillation energy requirement of less than or equal to 5 J in many of the patients represents a new benchmark.
If a de~brillation energy requirement of Յ5 J can be achieved in most patients, as was observed in the present study, then it may be possible to safely decrease the maximum energy in a de~brillator. Traditionally, a 10 J safety margin has been considered adequate. However, previous animal experiments and a recent clinical study suggests that de~brillation at twice the de~brillation energy requirement is highly effective [11] [12] [13] [14] . Another clinical study suggests that safety margins greater than twice the de~brillation energy requirement may be required in patients with low de~brillation energy requirements [10] . Although additional data are required to fully address this issue, a de~brillator with a maximum output of approximately 20 J may be reasonable for patients with de~brillation energy requirements less than or equal to 5 J. 
Mechanisms
There were two signi~cant differences between the two-electrode and the three-electrode de~brillation systems which were compared in the present study. The three-electrode de~brillation system included the generator shall as a shocking electrode, and utilized lower capacitance which resulted in a shorter pulse duration. These factors, either independently or in combination, can affect the energy, voltage, resistance, and current associated with the de~brillation energy requirement [1, 2, 8, 12, 15, 18, 19] . Because two factors were simultaneously changed, it is dif~cult to determine the relative contribution of each factor.
The improved de~brillation ef~cacy noted when the generator shell is used as a de~brillation electrode could be secondary to a more ef~cient de~brillation vector [8, 9, 15, 20] . With the use of an additional electrode in the left pectoral area, a greater portion of the left ventricle is in the path of the de~brillation current. Furthermore, a third electrode decreases the de~bril-lation impedance by increasing the de~brillation surface area. A lower impedance generates a greater de~brillation current which may improve de~brillation ef~cacy.
In previous studies, a decrease in capacitance has consistently been shown to result in a signi~cant rise in leading edge voltage and current, while having no effect on resistance. The results of the present study are consistent with these previous reports [1, 2, 15, 18, 19] . Lastly, the effect of lower capacitance on de~brillation ef~cacy has been variable [1, 2, 15, 18, 19] . Nonetheless, a decrease in capacitor size is advantageous because it results in a smaller de~brillator. In the present study, improved de~brillation ef~cacy was achieved despite a decrease in capacitance. This allows for a reduction in de~brillator size through the simultaneous bene~t of improved de~brillation ef~cacy and smaller capacitance.
Study limitations
A limitation of this study is that a de~brillation threshold curve was not constructed. The de~brillation threshold is not an absolute number but is a statistical phenomenon which is affected by the technique used to determine it [16] . Also, only an acute de~brillation energy requirement was determined, and therefore these data may not be applicable in the chronic setting. In addition, these results may not apply to other de~bril-lation systems.
Clinical implications
These data are the~rst to demonstrate a decrease in the de~brillation energy requirement with a threeelectrode de~brillation system that utilizes a transvenous lead with dual coils and a prepectoral de~brilla-tion electrode in conjunction with a 90 uF capacitor. This three-electrode system allowed for signi~cantly more patients to obtain a low de~brillation energy requirement, i.e., of less than or equal to 5 J. This may allow for smaller implantable de~brillators to be developed by combining lower maximum de~brillator output with smaller capacitors.
